Who Owns Olema Oncology Stock?
NASDAQ: OLMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 119.48%
- Institutions (% of float)
- 122.03%
- Held by insiders
- 2.08%
- Institutional holders
- 255
- Institutions 97.9%
- Insiders 2.1%
- Public and other 0.0%
Who owns Olema Oncology stock?
Institutional investors own about 119.5% of Olema Oncology's shares, spread across 255 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.08% of OLMA.
The largest institutional holders are FMR, LLC (13.07%), Paradigm Biocapital Advisors LP (9.90%) and Blackrock Inc. (8.20%). Together, the top 10 institutions control 71.0% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their OLMA positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of OLMA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 11.45M | 13.07% | -5.7% |
| Paradigm Biocapital Advisors LP | 8.67M | 9.90% | +8.1% |
| Blackrock Inc. | 7.18M | 8.20% | +7.0% |
| Jupiter Topco LLC | 7.09M | 8.10% | +100.0% |
| Bain Capital Life Sciences Investors, LLC | 7.09M | 8.09% | -5.2% |
| BVF Inc. | 5.30M | 6.05% | 0.0% |
| Siren, L.L.C. | 4.86M | 5.54% | 0.0% |
| State Street Corporation | 3.85M | 4.39% | -10.9% |
| Vanguard Capital Management LLC | 3.51M | 4.01% | +5.2% |
| Logos Global Management LP | 3.21M | 3.66% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of OLMA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.61M | 2.98% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.15M | 2.45% |
| iShares Trust-iShares Russell 2000 ETF | 2.03M | 2.32% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.68M | 1.92% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.64M | 1.88% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 858.92K | 0.98% |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 820.00K | 0.94% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 777.20K | 0.89% |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 693.87K | 0.79% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 652.25K | 0.74% |
Frequently asked questions
Who is the largest shareholder of Olema Oncology?
FMR, LLC is the largest institutional shareholder of OLMA, owning 13.07% of shares outstanding (11.45M shares) as of its latest 13F filing.
What percentage of Olema Oncology is owned by institutions?
Institutions own about 119.5% of OLMA shares and 122.0% of the public float.
How much of Olema Oncology do insiders own?
Insiders, such as officers and directors, own about 2.08% of OLMA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.